• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020年夏季(大规模疫苗接种前)、2021年夏季(首次大规模疫苗接种后)和2022年夏季(加强针大规模疫苗接种后)意大利新冠疫情趋势:一项基于5885万人口的全国性真实世界研究

Trends in the COVID-19 Pandemic in Italy during the Summers of 2020 (before Mass Vaccination), 2021 (after Primary Mass Vaccination) and 2022 (after Booster Mass Vaccination): A Real-World Nationwide Study Based on a Population of 58.85 Million People.

作者信息

Roncati Luca, Bartolacelli Giulia, Galeazzi Carlo, Caramaschi Stefania

机构信息

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy.

Department of Maternal, Infant and Adult Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy.

出版信息

Pathogens. 2023 Nov 22;12(12):1376. doi: 10.3390/pathogens12121376.

DOI:10.3390/pathogens12121376
PMID:38133261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10747560/
Abstract

UNLABELLED

Like all RNA viruses, SARS-CoV-2 shows a high mutation rate, which has led to the emergence of new variants. Among them, Gamma and Delta developed at the turn of 2020-2021 in Amazonas and India, two ecoregions characterized by hot-humid weather, very similar to that of the summer season in Italy due to climate change, the first Western country to be hit hard by COVID-19 and to experience lockdown restrictions in a democratic framework of 58.85 million people. The aim of our research has been to evaluate the impact of climate on the COVID-19 pandemic in Italy during the summers of 2020 (before mass vaccination), 2021 (after primary mass vaccination) and 2022 (after booster mass vaccination), also taking into account the emergence of these two variants.

METHODS

During the state of national health emergency and the Draghi government, the Civil Defense Department released the aggregate data coming from the Ministry of Health, the Higher Institute of Health, the Independent Provinces and the Italian Regions daily, in order to inform about the pandemic situation in Italy. Among these data there were the number of deaths, hospitalizations in intensive care units (ICU), non-ICU patients, contagions and performed swabs. By means of a team effort, we have collected and elaborated all these data, comparing the COVID-19 pandemic in Italy during the summers of 2020 (following the nationwide lockdown), 2021 and 2022.

RESULTS

from the summer of 2020 to the summers of 2021 and 2022 all pandemic trend indicators have shown a sharp worsening in Italy. COVID-19 deaths increased by ≈298% and ≈834%, ICU hospitalizations by ≈386% and ≈310%, non-ICU hospitalizations by ≈224% and ≈600%, contagions by ≈627% and ≈6850% (i.e., ≈68.50 times), swabs by ≈354% and ≈370%, and the mean positivity rate passed from ≈1% to ≈2% and ≈20%, respectively.

CONCLUSIONS

SARS-CoV-2 can be transmitted in any climate, including areas with hot and humid weather, and the emergence of variants adapted to hot-humid climates may result in summer COVID-19 outbreaks, even in neither tropical nor subtropical countries. Although COVID-19 vaccines can confer cross-protection against newly emerging variants, this cross-immunity is naturally not absolute but limited, considering that vaccine protection wanes significantly after 6 months. It follows that a subject vaccinated at the beginning of the winter will not be completely covered in the height of the summer, and we should not forget the unvaccinated. As a final remark, the long and strict nationwide lockdown made it possible to flatten SARS-CoV-2 circulation and, therefore, its negative impact on Italy during the summer of 2020.

摘要

未标注

与所有RNA病毒一样,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)显示出高突变率,这导致了新变种的出现。其中,伽马变种和德尔塔变种于2020年末至2021年初在亚马孙地区和印度出现,这两个生态区域的气候炎热潮湿,由于气候变化,与意大利夏季的气候非常相似,意大利是第一个受新冠疫情重创并在拥有5885万人口的民主框架下实施封锁限制的西方国家。我们研究的目的是评估气候对意大利在2020年夏季(大规模疫苗接种前)、2021年夏季(首次大规模疫苗接种后)和2022年夏季(加强针大规模疫苗接种后)新冠疫情的影响,同时也考虑这两个变种的出现情况。

方法

在国家卫生紧急状态和德拉吉政府执政期间,民防部门每天发布来自卫生部、高等卫生研究所、独立省份和意大利各地区的汇总数据,以便通报意大利的疫情形势。这些数据包括死亡人数、重症监护病房(ICU)住院人数、非ICU患者人数、感染人数和进行的拭子检测数量。通过团队努力,我们收集并整理了所有这些数据,比较了意大利在2020年夏季(全国封锁之后)、2021年和2022年夏季的新冠疫情情况。

结果

从2020年夏季到2021年和2022年夏季,意大利所有疫情趋势指标均显著恶化。新冠死亡人数增加了约298%和约834%,ICU住院人数增加了约386%和约310%,非ICU住院人数增加了约224%和约600%,感染人数增加了约627%和约6850%(即约68.50倍),拭子检测数量增加了约354%和约370%,平均阳性率分别从约1%升至约2%和约20%。

结论

SARS-CoV-2可在任何气候条件下传播,包括炎热潮湿地区,适应炎热潮湿气候的变种的出现可能导致夏季新冠疫情爆发,即使在既非热带也非亚热带的国家。尽管新冠疫苗可对新出现的变种提供交叉保护,但考虑到疫苗保护在6个月后会大幅减弱,这种交叉免疫自然不是绝对的,而是有限的。因此,在冬季初接种疫苗的人在夏季高峰期不会得到完全保护,而且我们不应忘记未接种疫苗的人群。最后需要指出的是,长期严格的全国封锁使得SARS-CoV-2的传播得以平缓,因此在2020年夏季对意大利的负面影响也得以减轻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/b892a077a2aa/pathogens-12-01376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/200edb583869/pathogens-12-01376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/d3a7de4b24de/pathogens-12-01376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/0390fc3d2e21/pathogens-12-01376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/fcd3309959b7/pathogens-12-01376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/68173c2e0c79/pathogens-12-01376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/b892a077a2aa/pathogens-12-01376-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/200edb583869/pathogens-12-01376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/d3a7de4b24de/pathogens-12-01376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/0390fc3d2e21/pathogens-12-01376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/fcd3309959b7/pathogens-12-01376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/68173c2e0c79/pathogens-12-01376-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed3/10747560/b892a077a2aa/pathogens-12-01376-g006.jpg

相似文献

1
Trends in the COVID-19 Pandemic in Italy during the Summers of 2020 (before Mass Vaccination), 2021 (after Primary Mass Vaccination) and 2022 (after Booster Mass Vaccination): A Real-World Nationwide Study Based on a Population of 58.85 Million People.2020年夏季(大规模疫苗接种前)、2021年夏季(首次大规模疫苗接种后)和2022年夏季(加强针大规模疫苗接种后)意大利新冠疫情趋势:一项基于5885万人口的全国性真实世界研究
Pathogens. 2023 Nov 22;12(12):1376. doi: 10.3390/pathogens12121376.
2
A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn-Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year.一项关于2020年秋冬季节(大规模接种疫苗前)和2021年(大规模接种疫苗后)意大利COVID-19趋势的全国性真实世界研究,并结合每年死亡负担的回顾性分析。
Microorganisms. 2024 Feb 21;12(3):435. doi: 10.3390/microorganisms12030435.
3
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
4
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
5
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比,使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
6
Boosters and time from the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment.加强针和距上次接种新冠疫苗的时间:通过实时流行病学评估来制定公共卫生决策。
Epidemiol Prev. 2022 Jan-Apr;46(1-2):34-46. doi: 10.19191/EP22.1.A001.001.
7
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
8
First Wave of COVID-19 Pandemic in Italy: Data and Evidence.意大利的 COVID-19 大流行第一波:数据和证据。
Adv Exp Med Biol. 2021;1353:91-113. doi: 10.1007/978-3-030-85113-2_6.
9
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.2021 年 12 月 1 日至 2022 年 5 月 31 日,在意大利东北部的的里雅斯特和戈里齐亚的医护人员中,奥密克戎传播期间的 SARS-CoV-2 初次感染、再感染和疫苗有效性。
Viruses. 2022 Nov 30;14(12):2688. doi: 10.3390/v14122688.
10
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET,14 个州,2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.

引用本文的文献

1
Exploring infectious disease spread as a function of seasonal and pandemic-induced changes in human mobility.探讨传染病传播作为人类流动性季节性和大流行引发变化的函数。
Front Public Health. 2024 Aug 27;12:1410824. doi: 10.3389/fpubh.2024.1410824. eCollection 2024.
2
A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn-Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year.一项关于2020年秋冬季节(大规模接种疫苗前)和2021年(大规模接种疫苗后)意大利COVID-19趋势的全国性真实世界研究,并结合每年死亡负担的回顾性分析。
Microorganisms. 2024 Feb 21;12(3):435. doi: 10.3390/microorganisms12030435.

本文引用的文献

1
Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study.老年人因 COVID-19 住院后死亡和再次入院的长期风险:回顾性队列研究。
BMJ. 2023 Aug 9;382:e076222. doi: 10.1136/bmj-2023-076222.
2
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
3
The influence of meteorological factors on COVID-19 spread in Italy during the first and second wave.气象因素对意大利第一波和第二波 COVID-19 传播的影响。
Environ Res. 2023 Jul 1;228:115796. doi: 10.1016/j.envres.2023.115796. Epub 2023 Apr 3.
4
Most COVID-19 Deaths Worldwide Were Among Older People.全球大多数新冠死亡病例发生在老年人中。
JAMA. 2023 Mar 7;329(9):704. doi: 10.1001/jama.2023.1554.
5
Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies.针对原始 SARS-CoV-2 感染具有低中和抗体水平的奥密克戎特异性 mRNA 疫苗诱导交叉保护免疫。
J Med Virol. 2023 Jan;95(1):e28370. doi: 10.1002/jmv.28370.
6
Associations between indoor relative humidity and global COVID-19 outcomes.室内相对湿度与全球 COVID-19 结局的关联。
J R Soc Interface. 2022 Nov;19(196):20210865. doi: 10.1098/rsif.2021.0865. Epub 2022 Nov 16.
7
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022.2021 年 1 月至 2022 年 4 月,13 个美国州 18 岁及以上接种和未接种疫苗的成年人因 COVID-19 住院的情况。
JAMA Intern Med. 2022 Oct 1;182(10):1071-1081. doi: 10.1001/jamainternmed.2022.4299.
8
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.奥密克戎变异株感染诱导的有限交叉免疫,未接种疫苗者尤其如此。
Nature. 2022 Jul;607(7918):351-355. doi: 10.1038/s41586-022-04865-0. Epub 2022 May 18.
9
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.BNT162b2 新冠病毒疫苗第三剂的安全性和有效性。
N Engl J Med. 2022 May 19;386(20):1910-1921. doi: 10.1056/NEJMoa2200674. Epub 2022 Mar 23.
10
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染和 COVID-19 疾病有效性的持续时间:系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.